Your browser doesn't support javascript.
loading
It Is All about Probiotics to Control Cervical Cancer.
Ashique, Sumel; Faruk, Abdul; Ahmad, Farhan Jalees; Khan, Tasneem; Mishra, Neeraj.
Afiliação
  • Ashique S; Department of Pharmaceutics, School of Pharmacy, Pandaveswar, West Bengal, 713346, India.
  • Faruk A; Department of Pharmaceutical Sciences, Hemwati Nandan Bahuguna Garhwal University, Srinagar, Uttarakhand, India. abdul_faruk@yahoo.com.
  • Ahmad FJ; Department of Pharmaceutics, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, 110062, India.
  • Khan T; Department of Pharmaceutics, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, 110062, India.
  • Mishra N; Amity Institute of Pharmacy, Amity University, Gwalior, 474005, Madhya Pradesh, India.
Article em En | MEDLINE | ID: mdl-37880560
Cervical cancer (CC) is the fourth most common malignancy in female patients. "Human papillomavirus" (HPV) contamination is a leading cause of all forms of cervical cancer, accounting for an expected 570,000 reported incidents in 2018. Two HPV strains (16 and 18) are responsible for 70% of CC and pre-cancerous cervical abnormalities. CC is one of the foremost reasons for the malignancy death rate in India among women ranging from 30 to 69 years of age in India, responsible for 17% of all cancer deaths. Currently approved cervical cancer treatments are associated with adverse reactions that might harm the lives of women affected by this disease. Consequently, probiotics can play a vital role in the treatment of CC. It is reflected from various studies regarding the role of probiotics in the diagnosis, prevention or treatment of cancer. In this review article, we have discussed the rationale of probiotics for treatment of CC, the role of probiotics as effective adjuvants in anti-cancer therapy and the combined effect of the anti-cancer drug along with probiotics to minimize the side effects due to chemotherapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Probiotics Antimicrob Proteins Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Probiotics Antimicrob Proteins Ano de publicação: 2023 Tipo de documento: Article